VCA Inc. (WOOF) to Post Q3 2016 Earnings of $0.83 Per Share, Northcoast Research Forecasts
VCA Inc. (NASDAQ:WOOF) – Investment analysts at Northcoast Research raised their Q3 2016 earnings estimates for VCA in a note issued to investors on Wednesday. Northcoast Research analyst E. Snyder now forecasts that the brokerage will post earnings of $0.83 per share for the quarter, up from their prior forecast of $0.82. Northcoast Research also issued estimates for VCA’s Q1 2017 earnings at $0.77 EPS and Q3 2017 earnings at $0.95 EPS.
VCA (NASDAQ:WOOF) last issued its earnings results on Wednesday, July 27th. The company reported $0.87 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.82 by $0.05. VCA had a return on equity of 16.86% and a net margin of 9.93%. The business earned $653.50 million during the quarter, compared to analysts’ expectations of $637.18 million. During the same period in the prior year, the business earned $0.70 EPS. The business’s revenue for the quarter was up 19.1% compared to the same quarter last year.
Several other research firms have also recently issued reports on WOOF. Zacks Investment Research raised VCA from a “hold” rating to a “buy” rating and set a $80.00 target price for the company in a research note on Friday, July 29th. Jefferies Group reissued a “hold” rating on shares of VCA in a research note on Friday, August 5th. Finally, Bank of America Corp. began coverage on VCA in a research note on Thursday. They set a “buy” rating for the company. One analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $71.00.
Shares of VCA (NASDAQ:WOOF) traded up 1.71% during midday trading on Friday, hitting $70.01. The company’s stock had a trading volume of 349,666 shares. VCA has a 12-month low of $44.00 and a 12-month high of $73.69. The firm has a 50-day moving average of $70.47 and a 200 day moving average of $65.67. The firm has a market cap of $5.66 billion, a price-to-earnings ratio of 24.98 and a beta of 1.30.
In other news, COO Arthur J. Antin sold 34,000 shares of the stock in a transaction dated Friday, September 16th. The shares were sold at an average price of $69.03, for a total transaction of $2,347,020.00. Following the transaction, the chief operating officer now owns 89,691 shares of the company’s stock, valued at $6,191,369.73. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director John B. Chickering, Jr. sold 2,302 shares of the stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $70.85, for a total transaction of $163,096.70. Following the transaction, the director now directly owns 10,992 shares in the company, valued at approximately $778,783.20. The disclosure for this sale can be found here. Insiders own 4.60% of the company’s stock.
Institutional investors have recently modified their holdings of the company. Acrospire Investment Management LLC bought a new position in shares of VCA during the first quarter valued at approximately $104,000. Walleye Trading LLC boosted its position in shares of VCA by 312.0% in the second quarter. Walleye Trading LLC now owns 2,052 shares of the company’s stock worth $139,000 after buying an additional 1,554 shares in the last quarter. Creative Planning boosted its position in shares of VCA by 43.5% in the second quarter. Creative Planning now owns 2,554 shares of the company’s stock worth $173,000 after buying an additional 774 shares in the last quarter. Bessemer Group Inc. boosted its position in shares of VCA by 58.1% in the second quarter. Bessemer Group Inc. now owns 3,004 shares of the company’s stock worth $203,000 after buying an additional 1,104 shares in the last quarter. Finally, Wedbush Securities Inc. acquired a new position in shares of VCA during the second quarter worth about $208,000. 91.17% of the stock is currently owned by institutional investors and hedge funds.
VCA Company Profile
VCA Inc is an animal healthcare company. The Company operates through five segments. Its Animal Hospital segment provides veterinary services for companion animals and sells related retail and pharmaceutical products. Its Laboratory segment provides diagnostic laboratory testing services for veterinarians, both associated with its animal hospitals and those independent of the Company.
Receive News & Stock Ratings for VCA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VCA Inc. and related stocks with our FREE daily email newsletter.